This is not the most recent version of the article. View current version (15 OCT 2013)

Intervention Protocol

Long-acting beta2-agonists for chronic obstructive pulmonary disease

  1. Charlotta Karner1,*,
  2. Elizabeth Stovold2

Editorial Group: Cochrane Airways Group

Published Online: 17 OCT 2012

DOI: 10.1002/14651858.CD010177


How to Cite

Karner C, Stovold E. Long-acting beta2-agonists for chronic obstructive pulmonary disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD010177. DOI: 10.1002/14651858.CD010177.

Author Information

  1. 1

    BMJ Group, BMJ Evidence Centre, London, UK

  2. 2

    St George's, University of London, Population Health Sciences and Education, London, UK

*Charlotta Karner, BMJ Evidence Centre, BMJ Group, Tavistock Square, London, WC1H 9JR, UK. ckarner@bmjgroup.com. lottakarner@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 17 OCT 2012

SEARCH

This is not the most recent version of the article. View current version (15 OCT 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of long-acting beta2-agonists compared with placebo for patients with chronic obstructive pulmonary disease (COPD), upon clinically-important endpoints.